Possible long-term risks include: Gallstones or gallbladder inflammation, especially with rapid weight loss Pancreatitis, which is inflammation of the pancreas Kidney stress or acute kidney injury linked with dehydration from vomiting or diarrhoea Severe constipation or worsening digestive symptoms Delayed stomach emptying or gastroparesis-like symptoms Possible worsening of diabetic retinopathy in some people with type 2 diabetes, especially if blood sugar improves very quickly Increased heart rate in some people Allergic reactions, such as swelling, rash, itching, or breathing difficulty Mood changes or suicidal thoughts, which need immediate medical attention Loss of lean muscle mass if weight loss happens without enough protein and strength training Facial volume loss due to rapid weight loss, sometimes called Ozempic face, although this can happen with rapid weight loss from any cause Some GLP-1 medicines carry a warning related to thyroid C-cell tumours seen in animal studies
Maternal Age : Higher risk in mothers younger than 20 or older than 39 years (Shaye, 2015
What the clinical trials tell us about injection sites The landmark phase 2 trial for retatrutide, published in the New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with obesity
For weekly injectable GLP-1 medications (follow product-specific guidelines): Semaglutide (Ozempic) : If you miss your scheduled dose and remember within five days , administer the missed dose as soon as possible, then resume your regular weekly schedule
Use labs to guide therapy: fasting insulin can signal metformin benefit
However, the representative was knowledgeable about everything else I asked her
